NASHVILLE, Tenn., Aug. 8, 2019 /PRNewswire/ -- OneOncology announced today that its partner practices have already begun administering two biosimilars from Amgen, MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin® (trastuzumab),

COSTA MESA, Calif., Aug. 8, 2019 /PRNewswire/ -- Experian, the global information services company, announced today that it has signed a definitive agreement to acquire MyHealthDirect, which offers a digital care coordination platform that optimizes scheduling for providers, payers, and consumers. This acquisition further solidifies Experian's position as a leading

PALO ALTO, Calif., Aug. 8, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that management will present at the Wedbush PacGrow Healthcare Conference in New York, NY on

NEW YORK, Aug. 8, 2019 /PRNewswire/ -- Dadi, the health company that makes male fertility testing and sperm storage more affordable and accessible, today announced the close of a

SAN DIEGO, Aug. 8, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today is hosting its 2019 Investor Day in New York City with presentations by Chief Executive Officer

SAN JUAN, Puerto Rico, Aug. 8, 2019 /PRNewswire/ -- Triple-S Management Corporation (NYSE: GTS), a leading managed care company in Puerto Rico, today announced its second quarter 2019 results.

BOCA RATON, Fla., Aug. 8, 2019 /PRNewswire/ -- Power Supplements now offers its no jitters, no crash Patria Energy Drink on the popular online health and wellness portal,

STOCKHOLM, Aug. 8, 2019 /PRNewswire/ -- The second quarter of 2019 was eventful. We increased our market coverage, secured funding for a very interesting research and development project, broadened the clinical evidence and strengthened executive management. Revenues and earnings were weaker than last year, but one must bear in mind that the second quarter 2018 was ve

VANCOUVER, British Columbia, Aug. 8, 2019 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE: MYM.CN) (CSE: MYM) (OTCBB: MYMMF) ("MYM Nutraceuticals" or the "Company") is pleased to announce that it has expanded the scope of its global offices to include distribution and sales of the newly formed MYM International Brands Inc. MYM recently incorporat

BOCA RATON, Fla., Aug. 7, 2019 /PRNewswire/ -- IM HealthScience®, innovators of medical foods and dietary supplements, today announced the results of a high-quality, nationwide survey conducted among a representative and projectable sample of U.S. gastroenterologists, which again confirmed IBgard's "#1 Recommended"1 rating